Hydronephrosis is a condition characterized by a swollen kidney as a result of abnormal drainage of urine from the kidney to the bladder. It is a secondary disease that results from primary disease that may affect the kidney. 
This report contains market size and forecasts of Hydronephrosis Treatment in Global, including the following market information:
Global Hydronephrosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hydronephrosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hydronephrosis Treatment include NephroGenex, PHRAXIS, Allergan, Amgen, Anthem Group, Sanofi and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hydronephrosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hydronephrosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hydronephrosis Treatment Market Segment Percentages, by Type, 2021 (%)
Surgical Treatment
Drug Treatment
Global Hydronephrosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hydronephrosis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Ambulatory Surgery Centre
Global Hydronephrosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hydronephrosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hydronephrosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hydronephrosis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
NephroGenex
PHRAXIS
Allergan
Amgen
Anthem Group
Sanofi
Novartis